SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
SCMP
Delisted
SCMP was delisted on the 12th of February, 2018.
188 hedge funds and large institutions have $645M invested in Sucampo Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 52 increasing their positions, 56 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
6% more funds holding
Funds holding: 178 → 188 (+10)
7% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 56
Holders
188
Holding in Top 10
3
Calls
$11.5M
Puts
$8.23M
Top Buyers
| 1 | +$28.7M | |
| 2 | +$26.8M | |
| 3 | +$17.6M | |
| 4 |
PCM
Prelude Capital Management
New York
|
+$12M |
| 5 |
Renaissance Technologies
New York
|
+$11.7M |
Top Sellers
| 1 | -$27.4M | |
| 2 | -$22M | |
| 3 | -$14.8M | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$10.5M |
| 5 |
Goldman Sachs
New York
|
-$8.85M |